Medication for the treatment of diseases of the urinary tract

Experts Jury survey results of 2019 in category

Gynecology, urology, nephrology / Medication for the treatment of diseases of the urinary tract

1.		Канефрон Н (Bionorica)	80.00%	5

2.	3	Уролесан (Arterium Corporation)	70.00%	4.38

–.	4	~~Фітолізин Плюс (Farmak)~~	~~40.00%~~	~~2.50~~

3.	2	Урохолум (Vishpha \| Фармацевтична фабрика Vishpha)	30.00%	1.88

3.	7	Берёзы почки (Ternopharm)	30.00%	1.88

5.	~	Nephrocare (Delta Medical)	20.00%	1.25

5.	6	Афлазин (Валартін Фарма)	20.00%	1.25

5.	3	Цистон (Фірма ТК Комфорт)	20.00%	1.25

8.	~	Diurol (Валартін Фарма)	10.00%	0.63

8.	5	Блемарен (Esparma)	10.00%	0.63

8.	7	Нефрофіт (Aim)	10.00%	0.63

8.	~	Уро-Ваксом (Astellas Europe)	10.00%	0.63

8.	7	Уро-гран (Національна гомеопатична спілка)	10.00%	0.63

–.	7	Еспа-фоцин (Esparma)	0.00%	0

–.		Уронат Медивит (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	0.00%	0

–.		Уростон (Progress pharma)	0.00%	0

–.		Фітоліт (Pharmaceutical company “Zdorovya”)	0.00%	0

–.	6	Цисто-аурин (Esparma)	0.00%	0

The participant which took the 1st place in this rating is by opinion of industry specialists is the best choice in 2019, recommendation of an experts #1 in the category “Medication for the treatment of diseases of the urinary tract”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.